332 related articles for article (PubMed ID: 22576688)
1. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer.
Wang Y; Chen W; Yang C; Wu W; Wu S; Qin X; Li X
Int J Oncol; 2012 Jul; 41(1):276-84. PubMed ID: 22576688
[TBL] [Abstract][Full Text] [Related]
2. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion.
Wang F; Li X; Xie X; Zhao L; Chen W
FEBS Lett; 2008 Jun; 582(13):1919-27. PubMed ID: 18501714
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells.
Yang C; Li X; Wang Y; Zhao L; Chen W
Gene; 2012 Mar; 496(1):8-16. PubMed ID: 22285928
[TBL] [Abstract][Full Text] [Related]
4. Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR.
Tsang WP; Wong TW; Cheung AH; Co CN; Kwok TT
RNA; 2007 Jun; 13(6):890-8. PubMed ID: 17416635
[TBL] [Abstract][Full Text] [Related]
5. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma.
Wang XS; Zhang Z; Wang HC; Cai JL; Xu QW; Li MQ; Chen YC; Qian XP; Lu TJ; Yu LZ; Zhang Y; Xin DQ; Na YQ; Chen WF
Clin Cancer Res; 2006 Aug; 12(16):4851-8. PubMed ID: 16914571
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling.
Fan Y; Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y
FEBS J; 2014 Apr; 281(7):1750-8. PubMed ID: 24495014
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel putative non-coding RNA involved in proliferation arrest of a non-small cell lung carcinoma cell line treated with an original chemical substance, methyl-4-methoxy-3-(3-methyl-2-butanoyl) benzoate.
Jacquot C; Carbonnelle D; Tomasoni C; Papaconstadinou A; Roussis V; Roussakis C
Int J Oncol; 2004 Aug; 25(2):519-27. PubMed ID: 15254752
[TBL] [Abstract][Full Text] [Related]
8. Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Zhang ZW; Guo YL
Cancer Gene Ther; 2004 Apr; 11(4):263-72. PubMed ID: 14963492
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
Pan J; Li X; Wu W; Xue M; Hou H; Zhai W; Chen W
Cancer Lett; 2016 Nov; 382(1):64-76. PubMed ID: 27591936
[TBL] [Abstract][Full Text] [Related]
10. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells.
Gao J; Zhu J; Li HY; Pan XY; Jiang R; Chen JX
Int J Biochem Cell Biol; 2011 Sep; 43(9):1294-304. PubMed ID: 21601006
[TBL] [Abstract][Full Text] [Related]
11. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis.
Kanehira M; Harada Y; Takata R; Shuin T; Miki T; Fujioka T; Nakamura Y; Katagiri T
Oncogene; 2007 Sep; 26(44):6448-55. PubMed ID: 17452976
[TBL] [Abstract][Full Text] [Related]
12. The role of c-FLIP in cisplatin resistance of human bladder cancer cells.
Lee S; Yoon CY; Byun SS; Lee E; Lee SE
J Urol; 2013 Jun; 189(6):2327-34. PubMed ID: 23313194
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis.
Olivieri M; Ferro M; Terreri S; Durso M; Romanelli A; Avitabile C; De Cobelli O; Messere A; Bruzzese D; Vannini I; Marinelli L; Novellino E; Zhang W; Incoronato M; Ilardi G; Staibano S; Marra L; Franco R; Perdonà S; Terracciano D; Czerniak B; Liguori GL; Colonna V; Fabbri M; Febbraio F; Calin GA; Cimmino A
Oncotarget; 2016 Apr; 7(15):20636-54. PubMed ID: 26943042
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.
Karam M; Legay C; Auclair C; Ricort JM
Exp Cell Res; 2012 Mar; 318(5):558-69. PubMed ID: 22245102
[TBL] [Abstract][Full Text] [Related]
15. Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
Tsunoda T; Koga H; Yokomizo A; Tatsugami K; Eto M; Inokuchi J; Hirata A; Masuda K; Okumura K; Naito S
Oncogene; 2005 Feb; 24(8):1396-402. PubMed ID: 15608674
[TBL] [Abstract][Full Text] [Related]
16. The H19 non-coding RNA is essential for human tumor growth.
Matouk IJ; DeGroot N; Mezan S; Ayesh S; Abu-lail R; Hochberg A; Galun E
PLoS One; 2007 Sep; 2(9):e845. PubMed ID: 17786216
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells.
Nagatani G; Nomoto M; Takano H; Ise T; Kato K; Imamura T; Izumi H; Makishima K; Kohno K
Cancer Res; 2001 Feb; 61(4):1592-7. PubMed ID: 11245470
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.
Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD
Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.
Yoshino H; Enokida H; Chiyomaru T; Tatarano S; Hidaka H; Yamasaki T; Gotannda T; Tachiwada T; Nohata N; Yamane T; Seki N; Nakagawa M
Biochem Biophys Res Commun; 2012 Jan; 417(1):588-93. PubMed ID: 22178073
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterisation of a novel antisense non-coding RNA from the RBM5 gene locus.
Rintala-Maki ND; Sutherland LC
Gene; 2009 Sep; 445(1-2):7-16. PubMed ID: 19559772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
